ArticleCell journal2018

COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial.

Mohammad Hassan Naseri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.